Announced Wed, 3 Dec · 15:17 IST

Receipt of Letter of Authorization from Integra Medical Devices India Private Limited.

Govt Defence OrderBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shukra Pharmaceuticals has received an Authorization Letter from Integra Medical Devices India Pvt Ltd, making it the Authorized Distributor for all DGAFMS (Directorate General Armed Forces Medical Services) purchases across India. The company can now promote, market, and supply Integra's medical equipment and devices to Defence Hospitals, Commands, and related defence organizations pan-India. The authorization is valid until 31 December 2026. The management expects this to enhance revenue visibility, improve margins through premium medical device offerings, and strengthen the company's presence in the defence healthcare segment.

Likely market impact

Positive for shareholders as it opens a new high-value, stable revenue stream from the defence healthcare sector with long-term contract potential, though actual revenue contribution and order values have not been disclosed yet.